Structural Heart
L1 subspecialty spine topic for Structural Heart Disease (seeded from backend/data/cardiology_taxonomy.yaml).
Also called TAVR, MitraClip, LAAO, valvular heart disease
Sources: 12 new papers · 5 key papers · updated Oct 20, 2026
Unverified · drafted by AI from the sources cited below
Valvular heart disease is a leading cause of cardiovascular morbidity and mortality.1
Deep learning analysis of electrocardiography can identify valvular abnormalities, demonstrating an area under the receiver-operating characteristic of 0.84 with a sensitivity of 78% and specificity of 73% for combined detection of aortic and mitral disease.1 Deep learning models have also been assessed for echocardiographic diagnosis using data from 16 studies identified among 749 records.2 Women have historically been underrepresented in landmark diagnostic and clinical studies.3
Clinical practice guidelines provide optimal management strategies for patients with valvular heart disease.1 Transcatheter aortic valve replacement is utilized for aortic stenosis, with redo procedures showing 30-day mortality rates of 1.5 to 6.2% compared to 11.9 to 13.6% for surgical explantation.2 Left atrial appendage occlusion has been evaluated alongside transcatheter interventions in 652 patients, comparing 289 individuals who received the combined procedure against 363 who received medical therapy.3
Future research must address discrepancies between major international clinical guidelines.1 The long-term durability of transcatheter valves in younger cohorts remains an ongoing concern.2 Additionally, the potential role of sodium-glucose cotransporter-2 inhibitors in modifying disease processes like fibrosis and adverse remodeling requires further clinical validation.3
Task Force 5: Clinical Considerations for Myocarditis and Selected Cardiovascular Conditions, Including Valvular Heart Disease
Medicine & Science in Sports & Exercise — Guseh J — Nov 2026
Valvular Heart Disease and the Importance of Inspiratory Muscle Training in Cardiovascular Rehabilitation
Cureus — Bordoni B — Nov 2026
Prevalence and Consequences of Guideline-Directed Indications for Aortic Valve Replacement in the EARLY TAVR Trial
JACC: Cardiovascular Interventions — Madhavan M — Nov 2026
Perioperative Care of Heart Failure, Arrhythmias, and Valvular Heart Disease
Cardiac Electrophysiology Clinics — O’Glasser A — Oct 2026
Prevalence of Structural Heart Disease Detected By Echocardiography among Adults Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Eastern Nepal
International Journal of Medical Sciences and Academic Research — Mishra S — Oct 2026
Does dapagliflozin (Forxiga) affect the progression or improvement of regurgitation in valvular heart disease?
Tripdatabase — Oct 2026
Prevalence of atrial fibrillation among patients with rheumatic valvular heart disease in Ethiopia: A systematic review and meta-analysis
Journal of Medicine Surgery and Public Health — Kasaye R — Sep 2026
Diagnostic accuracy of deep learning models for detecting valvular heart diseases using echocardiography: a systematic review and meta-analysis
Scientific Reports — Avesta L — Sep 2026
Systemic inflammation and the emerging biology of valvular heart disease
European Journal of Preventive Cardiology — Dębski M — Aug 2026
New ESC/EACTS guidelines for the management of aortic valve disease: key takeaways and implications of long-term TAVR results based on recent explant and redo-TAVR registry outcomes
Journal of Cardiothoracic Surgery — Paul S — Aug 2026
Valvular Heart Disease Epidemiology
Medical Sciences — Aluru J
339 citations · 2022 · among the most cited on Structural Heart Disease
Sex Differences and Similarities in Valvular Heart Disease
Circulation Research — DesJardin J
199 citations · 2022 · among the most cited on Structural Heart Disease
The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management
Journal of Clinical Medicine — Santangelo G
180 citations · 2023 · among the most cited on Structural Heart Disease
Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease
Journal of the American College of Cardiology — Elias P
166 citations · 2022 · among the most cited on Structural Heart Disease
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases
Journal of the American College of Cardiology — Coisne A
155 citations · 2023 · among the most cited on Structural Heart Disease
A clinical question appears here only when its condition matches this topic, an outcome and a comparator were extracted from the studies, at least two studies and a patient count are on file, and the certainty is low or higher.
Supports benefit, no benefit shown, and mixed describe the direction of the measured effect. No benefit shown means the evidence does not support a benefit. It is not a finding of harm. Too little evidence means the question did not clear that bar.
Study count, RCT count, and patient count are separate. The patient total adds only studies that are linked into a study family and whose sample size is not flagged as implausible. A reversal is listed only when at least one randomized trial sits on each side of the change.
The overview is drafted from the guideline recommendations, trials, papers, and questions on this page, and every sentence has to cite one of them. It stays unverified until an NPI-verified clinician or a Synapse admin approves it. Approving records that person's name.